会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • USE OF PHENYLETHYLAMINE DERIVATIVES FOR THE ANITMICROBIAL TREATMENT OF SURFACES
    • 苯乙烯衍生物用于治疗表面抗微生物剂的用途
    • WO0162082A3
    • 2002-05-02
    • PCT/EP0101561
    • 2001-02-13
    • CIBA SC HOLDING AGHAAP WOLFGANGHOELZL WERNEROCHS DIETMARPUCHTLER KARINSCHNYDER MARCEL
    • HAAP WOLFGANGHOELZL WERNEROCHS DIETMARPUCHTLER KARINSCHNYDER MARCEL
    • A61K8/30A01N33/10A01N35/04A01N37/34A01N37/36A01N37/38A01N39/00A01N39/02A01N39/04A61K8/00A61K8/41A61K8/44A61K31/138A61K31/225A61K31/24A61K31/277A61P1/02A61P17/00A61Q1/00A61Q1/04A61Q1/06A61Q1/10A61Q1/12A61Q3/02A61Q3/04A61Q5/02A61Q5/04A61Q5/08A61Q5/10A61Q9/04A61Q11/00A61Q15/00A61Q17/02C07C213/06C07C217/60C07C253/30C07C255/54C09D11/00C09D201/00C11D3/48D06M13/328D21H21/36
    • A01N39/00A01N33/10A01N37/38A01N39/02A01N39/04C07C217/60C07C255/54C07C2601/08
    • The use of compounds of formula (1) is described, in which compounds R1, R2 and R3 are each independently of the others hydrogen; C1-C20alkyl; C3-C7cycloalkyl; C2-C20alkenyl; C4-C7cycloalkenyl; C2-C20alkynyl; C4-C7cycloalkynyl; or unsubstituted or C1-C5alkyl-, C3-C7cylcoalkyl-, C1-C5alkoxyl-, C3-C7cycloakoxy-, halo-, oxo-, carboxy-, carboxy-C1-C7alkyl ester-, carboxy-C3-C7cylcloalkyl ester-, cyano-, trifluoromethyl-, pentafluoroethyl-, amino-, N,N-mono- or di-C1-C20alkylamino- or nitro-substituted phenyl-C1-C5alkyl, naphthyl-C1-C5alkyl, phenylcarbonyl-C1-C5alkyl, naphthylcarbonyl-C1-C5alkyl, pyrrolylalkyl, furanylalkyl, thiophenylalkyl, pyrazolylalkyl, imidazolylalkyl, oxazolylalkyl, thiazolylalkyl, isoxazolylalkyl, isothiazolylalkyl, 1,2,3-triazolylalkyl, 1,2,4-triazolylalkyl, 1,2,3-oxadiazolylalkyl, 1,3,4-oxadiazolylalkyl, 1,2,3-thiadiazolylalkyl, 1,3,4-thiadiazolylalkyl, indolylalkyl, pyridylalkyl, pyridazinylalkyl, pyrimidinylalkyl, pyridazinylalkyl, quinolinylalkyl, isoquinolinylalkyl, pyrrolyl, furanyl, thiophenyl, pyrazolyl, imidazolyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, 1,2,3-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,3-thiadiazolyl, 1,3,4-thiadiazolyl, indolyl, pyridyl, pyridazinyl, pyrimidinyl, pyridazinyl, quinolinyl or isoquinolinyl; R4, R5, R6 and R7 are each independently of the others hydrogen; C1-C20alkyl; C3-C7 cycloalky; C2-C20 alkenyl; C4-C7 cycloalkenyl; C2-C20 alkynyl; or C4-C7 cycloalkynyl; and m and n are each independently of the other 0 or 1, for antimicrobial treatment of surfaces. The compounds exhibit a pronounced activity against pathogenic gram-positive and gram-negative bacteria, and also against yeasts and moulds. They are accordingly suitable for the antimicrobial treatment, especially preservation and disinfection, of surfaces.
    • 描述了式(1)化合物的用途,其中化合物R1,R2和R3各自独立地为氢; C1-C20烷基; C3-C7环烷基; C2-C20alkenyl; C4-C7cycloalkenyl; C2-C20alkynyl; C4-C7cycloalkynyl; 或未取代的或C 1 -C 5烷基 - ,C 3 -C 7烷基烷基 - ,C 1 -C 5烷氧基 - ,C 3 -C 7环烷氧基 - ,卤代 - ,氧代 - ,羧基 - ,羧基-C 1 -C 7烷基酯 - ,羧基-C 3 -C 7环烷基酯 - 氰基 - 三氟甲基 - ,五氟乙基 - ,氨基 - ,N,N-单或二-C 1 -C 20烷基氨基或硝基取代的苯基-C 1 -C 5烷基,萘基-C 1 -C 5烷基,苯基羰基-C 1 -C 5烷基,萘基羰基-C 1 -C 5烷基 ,吡咯基烷基,呋喃基烷基,噻吩基烷基,吡唑基烷基,咪唑基烷基,恶唑基烷基,噻唑烷基,异恶唑基烷基,异噻唑基烷基,1,2,3-三唑基烷基,1,2,4-三唑基烷基,1,2,3-恶二唑基烷基,1,3,4-恶二唑基烷基 1,2,3-噻二唑基烷基,1,3,4-噻二唑基烷基,吲哚基烷基,吡啶基烷基,哒嗪基烷基,嘧啶基烷基,哒嗪基烷基,喹啉基烷基,异喹啉基烷基,吡咯基,呋喃基,噻吩基,吡唑基,咪唑基,恶唑基,噻唑基,异恶唑基,异噻唑基, ,2,3-三唑基,1,2,4-三唑基,1,2,3-恶二唑基,1,3,4-恶二唑基,1,2,3-噻二唑基,1,3,4-噻二唑基,吲哚基, 吡啶基,哒嗪基,嘧啶基,哒嗪基,喹啉基或异喹啉基; R4,R5,R6和R7各自独立地为氢; C1-C20烷基; C3-C7环状; C2-C20烯基; C4-C7环烯基; C2-C20炔基; 或C 4 -C 7环炔基; m和n各自独立地为0或1,用于表面的抗微生物处理。 该化合物对病原性革兰氏阳性菌和革兰氏阴性细菌以及酵母和霉菌均表现出明显的活性。 因此它们适用于表面的抗菌处理,特别是保存和消毒。
    • 4. 发明申请
    • SILANYL PHENOLS AND NAPHTHOLS
    • SILANYL苯酚和萘酚
    • WO02058016A3
    • 2002-12-19
    • PCT/EP0200192
    • 2002-01-10
    • CIBA SC HOLDING AGHOELZL WERNERHAAP WOLFGANGKOPPOLD JUERGEN
    • HOELZL WERNERHAAP WOLFGANGKOPPOLD JUERGEN
    • A61L12/14C07C39/19C07C39/225C07F7/08C07F7/18D21H25/18
    • C07F7/0852C07F7/0818
    • There are described silanyl phenols and naphthols of formula (1a) or (1b), wherein R1 is hydrogen; halogen; hydroxy; C1-C20alkyl; C3-C12cycloalkyl; C1-C20alkoxy; trifluoromethyl; pentafluoroethyl; mono- or di-C1-C5alkylamino; hydroxy-C1-C5alkyl; or phenyl, phenyl-C1-C20alkyl, phenoxy, phenyl-C1-C20alkoxy, naphthyl or naphthyl-C1-C20alkyl each unsubstituted or substituted by C1-C5alkyl, C3-C12cycloalkyl, C1-C5alkoxy, C3-C12cycloalkoxy, halogen, oxo, carboxy, carboxy-C1-C7alkyl ester, carboxy-C3-C12cycloalkyl ester, cyano, trifluoromethyl, pentafluoroethyl, amino, N,N-mono- or di-C1-C20alkylamino or by nitro; R2, R3 and R4 are each independently of the others hydrogen; C1-C20alkyl; or C3-C12-cycloalkyl; R5, R6 and R7 are each independently of the others C1-C20alkyl, C5-C10aryl, C1-C20alkoxy, phenyl-C1-C20alkyl, phenyl-C1-C20alkoxy, C2-C5alkenyl, -O-Si-(C1-C5alkyl)3; or O-Si-(C1-C5alkyl)2-O-Si(C1-C5alkyl)3 and n is 0 or 1. The compounds exhibit a pronounced activity against Gram positive and Gram negative bacteria, and also against yeasts and moulds.
    • 描述了式(1a)或(1b)的硅烷基酚和萘酚,其中R 1是氢; 卤素; 羟基; C1-C20烷基; C3-C12环烷基; C1-C20alkoxy; 三氟甲基; 五氟; 单 - 或二-C 1 -C 5烷基氨基; 羟基C1-C5烷基; 或苯基,苯基-C 1 -C 20烷基,苯氧基,苯基-C 1 -C 20烷氧基,萘基或萘基-C 1 -C 20烷基,各自为未取代的或被C 1 -C 5烷基,C 3 -C 12环烷基,C 1 -C 5烷氧基,C 3 -C 12环烷氧基,卤素,氧代, ,羧基-C 1 -C 7烷基酯,羧基-C 3 -C 12环烷基酯,氰基,三氟甲基,五氟乙基,氨基,N,N-单或二-C 1 -C 20烷基氨基或被硝基取代; R2,R3和R4各自独立为氢; C1-C20烷基; 或C 3 -C 12 - 环烷基; R5,R6和R7各自独立地为C1-C20烷基,C5-C10芳基,C1-C20烷氧基,苯基-C1-C20烷基,苯基-C1-C20烷氧基,C2-C5链烯基,-O-Si-(C1-C5烷基)3 ; 或O-Si-(C 1 -C 5烷基)2 -O-Si(C 1 -C 5烷基)3并且n是0或1.所述化合物对革兰氏阳性菌和革兰氏阴性菌表现出显着的活性,并且还针对酵母菌和霉菌。
    • 9. 发明申请
    • POLYOL DERIVED ANTI-MICROBIAL AGENTS AND COMPOSITIONS
    • 聚氨酯衍生的抗微生物剂和组合物
    • WO2009138341A3
    • 2010-04-22
    • PCT/EP2009055453
    • 2009-05-06
    • BASF SEELDER STEWART TODDKHAWAM FADIHUANG XINYUHOELZL WERNER
    • ELDER STEWART TODDKHAWAM FADIHUANG XINYUHOELZL WERNER
    • A01P1/00
    • A01N37/36A01N37/44C07C229/12
    • Anti-microbial compositions are provided which comprise as an antimicrobial agent at least one compound derived from a select polyol containing at least 3 hydroxy groups wherein one or more, and often two or more, of the hydroxyls are derivitized to form certain ether, ester, carbonate or carbamate groups which groups may bear additional functionality. Antimicrobial compounds of this class are also provided. The compositions are effective against a variety of pathogens including fungi, Gram positive bacteria and Gram negative bacteria and are expected to have low human toxicity. Applications for the polyglycerol anti-microbial agents and compositions include those involving human and plant contact, such as cosmetics, hair care products, textiles and plant protections, as well as in applications with much less human contact, such as plastics, coatings, wood, paper and other materials of construction.
    • 提供抗微生物组合物,其包含作为抗微生物剂的至少一种衍生自包含至少3个羟基的选择多元醇的化合物,其中一个或多个,并且通常两个或更多个羟基被衍生以形成某些醚,酯, 碳酸酯或氨基甲酸酯基,这些基团可以具有附加的功能。 还提供了这一类的抗微生物化合物。 该组合物对各种病原体有效,包括真菌,革兰氏阳性菌和革兰氏阴性细菌,预计其毒性低。 聚甘油抗微生物剂和组合物的应用包括涉及人和植物接触的那些,例如化妆品,护发产品,纺织品和植物保护,以及在人类接触少得多的应用中,例如塑料,涂料,木材, 纸等施工材料。
    • 10. 发明申请
    • O-DERIVATIVES OF HALOGENATED DIPHENYL ETHER COMPOUNDS
    • 氢化二苯醚化合物的O-衍生物
    • WO9931036A2
    • 1999-06-24
    • PCT/EP9807997
    • 1998-12-09
    • CIBA GEIGY AGHOELZL WERNERHUEGLIN DIETMARMAIER THOMASMAO JIANWENOCHS DIETMAR
    • HOELZL WERNERHUEGLIN DIETMARMAIER THOMASMAO JIANWENOCHS DIETMAR
    • A01N31/16C07C25/02C07C39/24C07C41/00C07D251/00C07F9/12C07H15/203
    • C07H15/203A01N31/16C07C25/02C07C39/24C07D251/00C07F9/12
    • The invention describes O-derivatives of halogenated diphenyl ether compounds of formula (1), in which R1 and R2 independently of one another are F, Cl or Br; Y is a radical of formula (1a); (1b); (1c); (1d); (1e) or (1f); R3 is C1-C22alkyl; C1-C22alkoxy; phenyl; phenyl-C1-C4alkyl; --(CH2)p4-A R5R6R7; the radical of formula (I); R4 C1-C22alkyl; R5, R6, R7 and R8 independently of one another are hydrogen; C1-C4alkyl; sulfo-C1-C4alkyl; or R5 and R6 together with A form a cyclic radical unsubstituted or substituted by sulfo groups; or R7 and R8 together with N form a cyclic radical unsubstituted or substituted by sulfo groups; A is N or P; Z1 is fluorine, chlorine, the radical of formula (1g); Z2 is fluorine, chlorine, C1-C22alkoxy, C1-C22alkylthio or C1-C22-monoalkylamino or C1-C22dialkylamino; each of which is unsubstituted or substituted by OH, NH2 or sulfo; C6-C12aryloxy, C6-C12arylthio or C6-C12monoarylamino or C6-C12diarylamino, each of which is unsubstituted or substituted by OH, NH2 or sulfo; m is from 1 to 3; n is 1 or 2; and p1, p2, p3, p4 and p5 independently of one another are 1-4. The diphenyl ether derivatives according to the invention have excellent antimicrobial properties and are stable to migration.
    • 本发明描述了式(1)的卤代二苯醚化合物的O-衍生物,其中R 1和R 2彼此独立地是F,Cl或Br; Y是式(1a)的基团; (1B); (1C); (1D); (1e)或(1f); R3是C1-C22烷基; C1-C22alkoxy; 苯基; 苯基-C1-C4烷基; - (CH2)P4-A <+> R5R6R7; 式(I)的基团; R4 C1-C22烷基; R5,R6,R7和R8彼此独立地是氢; C1-C4烷基; 磺基C1-C4烷基; 或R 5和R 6与A一起形成未取代或被磺基取代的环状基团; 或R 7和R 8与N一起形成未取代或被磺基取代的环状基团; A是N或P; Z1是氟,氯,式(1g)的基团; Z 2是氟,氯,C 1 -C 22烷氧基,C 1 -C 22烷硫基或C 1 -C 22单烷基氨基或C 1 -C 22二烷基氨基; 其各自是未取代的或被OH,NH 2或磺基取代; C 6 -C 12芳氧基,C 6 -C 12芳硫基或C 6 -C 12单芳基氨基或C 6 -C 12二芳基氨基,其各自未被取代或被OH,NH 2或磺基取代; m为1〜3; n为1或2; 而p1,p2,p3,p4和p5彼此独立地为1-4。 根据本发明的二苯醚衍生物具有优异的抗菌性能并且对迁移稳定。